Neuroscience US 2026 (Light)

Where Big Attendance Meets Intimate Connections

Highlights of the Two-Day Event

October 12 - 13, 2026
Hilton San Diego Bayfront, CA


Cross-Programme Highlights


DAY ONE & TWO

AI & Digitalisation Zone

The AI & Digitalisation Zone will be hosted in the exhibition area and will serve as the central hub for AI-driven drug discovery, digital R&D, and next-generation platform technologies, bringing together innovators such as Recursion, Insitro, QT Sense, and other leaders across AI discovery platforms, cloud infrastructure, automation, bioinformatics, digital biology, academic hubs, and strategic pharma tech partners. This interactive space will feature poster presentations, live demos, and short tech talks, alongside an AI Networking Lounge and a coffee cart to foster meaningful connections and collaboration. 


DAY ONE

Sit down dinner – ‘Connecting Drug Discovery, Formulation, and Delivery from the Start’

Join fellow industry leaders for an exclusive VIP networking dinner designed to foster meaningful connections and conversations across the drug discovery, formulation, and delivery community. Limited seating available.


Championing the next generation of women leaders in life sciences

Our 'Women in Drug Discovery & Development' panel discussion brings together leaders and rising talent to explore career progression, leadership, and the evolving role of women across the drug discovery and development landscape. Through open discussion, the session will examine strategies for overcoming barriers, fostering mentorship and sponsorship, and driving greater diversity and influence in scientific innovation and decision-making.


DAY ONE

Neuroscience Leadership Roundtables

Bringing together leaders across neuroscience drug discovery and development, these interactive roundtables foster cross-functional collaboration to explore how earlier alignment on targets, biomarkers, brain delivery, and translation can reduce risk and accelerate the development of effective neurological therapies. 


Track Keynote Address


Jian Zuo

Co-Founder & Chief Executive Officer, Ting Therapeutics

Jian Zuo is an internationally recognised scientist and biotech entrepreneur pioneering regenerative therapies for hearing loss. A recipient of the 2025 Top Innovator Award at the New York Venture Summit, he is leading Ting Therapeutics in translating breakthrough neuroscience research into first-in-class therapies while advancing the future of hearing restoration. 


Other Highlights


DAY ONE & TWO

Closed-Door Discussions – Where Senior Leaders Speak Freely

This closed-door session offers an exclusive space for candid, off-the-record discussions. Connect with peers, share insights, and tackle the industry’s toughest challenges. Designed for executives shaping the future of the sector:

  Partnerships, Platforms Or Acquisitions: What Is The Winning Model For Brain Health Innovation?


Connect and Network

Experience an event that celebrates meaningful, one-on-one connections in a dynamic, bustling atmosphere. With Neuroscience Drug Development US 2026, enjoy a vibrant crowd with the warmth of personal interactions and curated experiences